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ABSTRACT: The reaction of Ir3(CO)9(3-Bi), 1 with BiPh3 has yielded a iridium-bismuth cluster complex Ir5(CO)10(3-Bi)2(4-
Bi), 2.  The first examples of bimetallic iridium-bismuth nanoparticles have been subsequently synthesized from 1 and 2 and these 
have been securely anchored on to the inner walls of mesoporous silica.  These isolated, bimetallic iridium-bismuth nanoparticles 
display a superior catalytic performance, when compared to their analogous monometallic counterparts and equivalent physical 
mixtures, in the C-H activation of 3-picoline to yield niacin.    
Probing the origins of the catalytic synergy between multi-
metallic active centers in porous solids, wherein a Platinum 
Group Metal (PGM) such as Ru, Pt or Rh, is alloyed with suit-
able oxophiles such as Sn, Bi or Mo facilitates the rational 
design of well-isolated, single-site nanoparticle catalysts, that 
exhibit enhanced stability and improved catalytic perfor-
mance.
1,2
 Tailoring suitable oxophiles in combination with 
multimetallic clusters has afforded intrinsic compositional 
control at the nanoscale, with the added advantage of control-
ling the morphology, size and shape of the ensuing naked-
metal nanoparticles.
3-5
  Such a design approach could be inte-
grated with bespoke support modifications (e.g. tuning the 
hydrophobicity) to yield both functional and structural syner-
gies facilitating structure-property relationships to be estab-
lished.
6
 The precise controlled synthesis of catalytically-active 
metal nanoparticles has been of great interest in recent years,
7,8
 
with the ever-expanding target of creating discrete single-sites.  
With a view to achieving this goal, a number of elegant strate-





 and framework extrusion processes
13
 have been 
developed.  Despite the intrinsic merits of these approaches,
9-13
 
the desire to modulate catalytic activity and selectivity at the 
nanoscale, through the adroit choice of appropriate metal 
combinations and their concomitant oxophilic analogues, for 
generating uniform, discrete, well-defined, multifunctional 
single-sites, remains a challenging prospect.
14
  
Bismuth on oxide supports has been shown to catalyze the 
oxidation of certain hydrocarbons heterogeneously.
15
 Bismuth 
molybdate is well known for its ability to catalyze the ammox-
idation of propene.
16
 We have recently shown that a bimetallic 
rhenium-bismuth catalyst, derived from a rhenium-bismuth 
complex Re2(CO)8(μ-BiPh2)2, can selectively convert 3-
picoline to 3-nicotinonitrile.
2
 The ability of the oxophile (bis-
muth in this case) to interact favorably with the mesoporous 
silica support, through the covalent-bond formation between 
the oxophilic metal and pendant silanol groups, renders this 
nanoparticle catalyst amenable for oxidation reactions.
3,5
 Fur-
thermore, the capping of the CO ligands on the nano-cluster 
precursor, improve the degree of site-isolation, leading to the 
creation of the catalytically active nanoparticle catalyst. It has 
been previously demonstrated
1-5
 that the subsequent removal 
of the CO ligands, generates uniform (< 5 nm), well-defined, 
anchored bimetallic nanoparticles, where the bismuth plays a 
pivotal role in securing the nanoclusters to the support and 
ensuring its compositional integrity.
3-5 
Furthermore, it has also 
been demonstrated that bismuth plays a key role in enhancing 
the catalytic efficiency in a range of selective oxidation reac-
tions.
17-19
 Most notable is the combination of bismuth with 




 species. While the 
exact role of bismuth in such catalysts is not conclusive, it has 
been suggested that the production of 2,5-furandicarboxylic 
acid (FDCA) from hydroxymethylfurfural (HMF) was appre-
ciably increased owing to the favourable interaction between 
Bi atoms and π-electrons in the furan ring.
18
 There are also 
other plausibilities attributing the promoter ability of Bi to its 
oxophilicity,
6,17
 which enhances the ability of bismuth to acti-
vate molecular oxygen thereby facilitating α-H abstraction.
19
 
These unique properties of the bismuth prompted us to devise 
other bimetallic catalysts and we report herein, for the first 
time, the design of two novel iridium-bismuth bimetallic 
nanoclusters that are derived from new Ir-Bi complexes.  Pre-
liminary catalytic studies, outlining the performance of these 
new iridium-bismuth nanoparticle catalysts for the direct oxi-
dation of 3-picoline to niacin are reported, offering a subtle 
contrast to the previously reported
2
 ammoxidation route to 
nicotinonitrile (precursor to niacin). Until recently, the only 
example of an iridium-bismuth complex was the compound 
Ir3(CO)9(μ3-Bi), 1 that was reported by Schmid.
20
 We have 
recently prepared a number of iridium-bismuth complexes 
containing germanium and tin ligands from complex 1 by re-
actions with HGePh3 and HSnPh3.
21
 We have now found that 1 
reacts with BiPh3 to yield the new higher nuclearity complex 
Ir5(CO)10(μ3-Bi)2(μ4-Bi), 2 in high yield (91%), see Scheme 1. 
Compound 2 was characterized crystallographically by single-
crystal X-ray diffraction and an ORTEP diagram of its molec-
ular structure is shown in Figure 2.
22
 The molecule lies on a 
 reflection plane in the solid state. Compound 2 contains five 
iridium atoms arranged in the form of a square pyramid.  
 
Scheme 1. A schematic of the transformation of 1 to 2 by 
reaction with BiPh3. CO ligands are shown only as lines. 
 
Complex 2 contains three bridging bismuth atoms: atom 
Bi(1) is a quadruple bridge that spans the base of the Ir5 square 
pyramid; the other two, Bi(2) and Bi(3), are triply-bridging 
ligands that bridge oppositely positioned triangular faces of 
the square pyramid. The Ir – Ir and Ir – Bi bond distances, 
Ir(1) – Ir(2) = 2.7824(7) Å, Ir(1) – Ir(3) = 2.8226(7) Å, Ir(2) – 
Ir(3) = 2.7903(7) Å, Ir(2) – Ir(2’) = 2.8255(9) Å, Ir(3) – Ir(3’) 
= 2.7796(9) Å, Ir(1) – Bi(3) = 2.8322(9), Ir(1) – Bi(2) = 
2.7623(9), Ir(2) – Bi(3) = 2.6868(7), Ir(2) – Bi(1) = 2.8004(7), 
Ir(3) – Bi(2) = 2.7002(7), Ir(3) – Bi(1) = 2.8185(7) are similar 
to those found in 1, (Ir – Ir av = 2.759(2) Å), (Ir – Bi av = 
2.734(2) Å).
7
   
 
Initial catalytic studies have revealed that two novel iridi-
um-bismuth catalysts (derived from the Ir3Bi and Ir5Bi3 cluster 
complexes, see details below) are indeed active for the direct 
oxidation of 3-picoline to niacin (Figure 1).
2
 Niacin is a key 
component of the NADH/NAD
+
 system that is known play an 
key role in many processes related to human metabolism.
23
 
Also known as vitamin B3, niacin is an essential food element; 
deficiencies can lead to the disorder known as Pellagra.
23
 Nia-
cin is also known to exhibit benefits for treatments of choles-
terol-related problems.
24
 Therefore the synthesis of niacin is of 
great interest, as evidenced by the range of industrial processes 
employed to produce it, by direct oxidation as well as via its 
precursor,  nicotinamide, that is  generated by ammoxidation 
of 3-picoline followed by hydrolysis – see Scheme 3, of refer-
ence 2,
25-27
  Industrially viable routes for niacin production are 
well-established with solid, metal-oxide catalysts yielding 




 and microbial biocatalysts (Rhodo-
coccus rhodochrous) producing nictonamide in a continuous 
fashion, albeit in a multi-step fashion.
27
 Whilst our previous 
work with the Re-Bi catalysts achieve C-H activation of 3-
picoline via ammoxidation  to achieve low yields (< 5 mol%) 
of niacin using an excess of sacrificial NH3;
2
 we have adopted 
a more direct oxidative approach, as a proof-of-concept study, 
with these novel IrBi catalysts for the single-step oxidation of 
3-picoline to niacin.  
 
Figure 1. The oxidation of 3-picoline to niacin using APB. 
 
 
Figure 2. An ORTEP diagram of the molecular structure of 
Ir5(CO)10(μ3-Bi)2(μ4-Bi), 2 showing 30% thermal ellipsoid 
probability. Selected interatomic bond distances (Å) and an-
gles (
o
) are as follows: Ir(1) – Ir(2) = 2.7824(7), Ir(1) – Ir(3) = 
2.8226(7), Ir(2) – Ir(3) = 2.7903(7), Ir(2) – Ir(2’) = 2.8255(9), 
Ir(3) – Ir(3’) = 2.7796(9), Ir(1) – Bi(3) = 2.8322(9), Ir(1) – 
Bi(2) = 2.7623(9), Ir(2) – Bi(3) = 2.6868(7), Ir(2) – Bi(1) = 
2.8004(7), Ir(3) – Bi(2) = 2.7002(7), Ir(3) – Bi(1) = 2.8185(7). 
 
Compounds 1 and 2 were deposited onto mesoporous 
(MCM-41) silica supports by the incipient wetness method 
and then both were converted into bimetallic IrBi nanoparti-
cles by thermal treatments under vacuum. They were subse-
quently evaluated for their ability to oxidize 3-picoline to nia-
cin catalytically by using acetylperoxyborate (APB) as the 
oxidant. Representative high angle annular dark field 
(HAADF) high resolution transmission electron microscopy 
images of the Ir3Bi and Ir5Bi3 nanoparticles after use in cataly-
sis are shown in Figure 3. As can be seen the particles are uni-
formly dispersed and are less than 2 nm in diameter. It can 
also be seen that the porous character of the support was main-
tained during the calcination/particle formation process. Anal-
ysis of their compositions by energy dispersive X-ray emission 
spectroscopy (EDS) are consistent with the Ir3Bi and Ir5Bi3 
compositions of the precursor complexes, see Supporting In-





Figure 3. HAADF - HRTEM images of Ir3Bi (a) and Ir5Bi3 
(b) nanoparticles on MCM-41 after use in catalysis at 65 oC. 
The catalysts were preconditioned/activated at 300 C for 2h 
before use. 
 
The Ir3Bi nanoparticles obtained from 1 were tested for the 
direct oxidation of 3-picoline to niacin by using the oxidant 
APB. APB has been shown to be a useful reagent for selective 
oxidation reactions under mild conditions, serving as a solid 
source of active oxygen by liberating peroxyacetic acid (PAA) 
in situ when dissolved in water.
28
 For comparisons, supported 
forms of pure Ir and pure Bi, 3Ir/1Bi (created from a solution 
of a mixture of Ir4(CO)12 and BiPh3 combined in the appropri-
ate ratio), Ir5Bi3 nanoparticles obtained from compound 2 and 
5Ir/3Bi particles (created from a solution of a mixture of 
Ir4(CO)12 and BiPh3 combined in the appropriate ratio) were 
also tested. The best catalytic results were obtained by pre-
heating the nanoparticles to 300 
o
C for 2 h under vacuum be-
fore use. The catalytic tests were performed at 65 
o
C for a pe-
riod of 45 min. The results of the various tests are shown in 
the chart in Figure 4 where blue represents the conversion of 
3-picoline, red represents the selectivity of the conversion to 
niacin and purple represents the turnover number (TON) for 
niacin formation. (See also Figures S3-S6 for further catalytic 
details on nature of support, the effect of calcination tempera-
ture on the reactivity and selectivity along with catalyst recy-
cle studies). 
 
Figure 4. Comparisons of catalytic behavior of the monome-
tallic and bimetallic Ir and Bi catalysts on MCM-41. The ex-
periments with the physical mixtures further highlight the mer-
its of the bimetallic cluster-based analogues. Reaction condi-
tions: 15 mmol of 3-picoline, 3:1 molar ratio of pico-
line:peroxyacetic acid (yielded from APB), 25 ml of H2O, 150 
mg of catalyst, 3.5 mmol of monoglyme internal standard, 65 
o
C, 45 minutes.  
 
Pure Ir and pure Bi are ineffective catalysts as represented 
by the very low TONs for Niacin. The principal side product is 
3-picoline-N-oxide, 3, which is the major product of oxidation 
with pure Bi on the support. The contrasting catalytic behav-
iors and catalytic opportunities afforded through the utilization 
of bimetallic nanoclusters are outlined in Figure 5. The mon-
ometallic Ir and Bi catalysts display distinctly different cata-
lytic profiles (see also Figures S7-10 for kinetic profiles); 
while Ir clearly shows an increased selectivity for niacin, it is 
far less active than its Bi counterpart, which has a greater pro-
pensity for the formation of picoline N-oxide. This difference 
in activity suggests that the monometallic Ir catalysts facilitate 
a targeted reaction pathway necessary to form niacin from 
picoline; whereas the monometallic Bi catalysts is far more 
proficient in activating the oxidant, which evokes a more di-
verse range of oxidation products. 
The bimetallic catalysts derived from 1 and 2 are superior to 
the bimetallics derived by co-impregnation (the physical mix) 
and they exhibit the best selectivity and TONs for niacin.  
 
Figure 5. A schematic representation of the contrasting cata-
lytic behaviors afforded by the Ir/Bi containing catalysts. 
 
The attributes of the two individual metal centers are max-
imized by combining them to generate intimately mixed bime-
tallic IrBi nanoclusters, which display vastly enhanced selec-
tivity towards the desired niacin along with a concomitant 
increase in catalytic efficiency (TON). The differing behavior 
of the 3Ir:1Bi and Ir3Bi catalysts (the former being a physical 
mixture (prepared using identical moles of monometallic Ir 
and Bi) strongly suggests that a specific structural integrity of 
the cluster is fundamental in optimizing the overall selectivity 
and efficiency of the catalysts in the oxidation reaction. 
Through careful synthetic design of the bimetallic precursor, 
one can ensure that the Ir and Bi metals are in close proximity 
to one another; a feature that cannot be readily controlled or 
guaranteed with the preparation of the bimetallic physical mix-
ture. By using a cluster-based precursor, where the structural 
and compositional integrity can be controlled at the molecular 
level, it is possible to exploit the individual benefits of the two 
metals to facilitate a synergistic enhancement in overall cata-
lytic behavior resulting in significant improvements in catalyt-
ic turnover. Thus, the Bi atoms are able to readily activate the 








































 via CH activation processes upon the 3-picoline, ultimately 
creating an effective spill-over catalyst.  
   The catalyst derived from Ir5Bi3 cluster exhibited the best 
activity both for conversion and for catalytic efficiency 
(TON). This may be attributed to the Ir/Bi ratio becoming 
closer to unity, thereby promoting a more efficient transfer of 
activated intermediates between the two metal sites. As with 
the Ir3Bi, the cluster derived Ir5Bi3 catalyst was far superior to 
the analogous physical mixture catalyst (5Ir:3Bi), further high-
lighting the importance of the structural and compositional 
integrity provided by the cluster precursor. 
In summary, the first iridium-bismuth cluster complex 2 has 
been synthesized and structurally characterized. The first ex-
amples of bimetallic IrBi nanoparticles have been synthesized 
from the bimetallic IrBi molecular cluster complexes 1 and 2. 
In a proof-of-concept study, these bimetallic nanoparticles 
exhibit superior catalytic activity for the direct oxidation 3-
picoline to niacin, compared to their monometallic analogues. 
By using cluster-based bimetallic precursors, where the com-
positional integrity can be better controlled at the molecular 
level, it is possible to produce superior nano-catalysts in order 
to better exploit the benefits of the individual metals by syner-
gistic complementarity in the overall catalytic behavior. It is 
believed that these new iridium-bismuth catalysts will exhibit 
superior catalytic activity for other types of hydrocarbon oxi-
dation reactions and will pave the way to an emerging family 
of precious metal-heavy main group metal bimetallic cata-
lysts.
2, 16, 29 
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